The current valuation score of Ironwood Pharmaceuticals Inc is 6.36, ranking 134 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 6.72, which is 12216.67% below the recent high of 828.21 and 10014.29% above the recent low of -666.67.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.